Defensins are smalL cysteine-rich antimicrobial peptides that are abundant in human, rabbit, and guinea pig neutrophils (PMN). Three defensins (human neutrophil peptide defensin constitute between 30 and 50% of the total protein in azurophil granules of human PMN. We examined the mechanism of HNP-mediated bactericidal activity against Escherichia coli ML-35 (i-, y-, z+) and its pBR322-transformed derivative, E. coli ML-35p. Under conditions that supported bactericidal activity, HNP-1 sequentially permeabilized the outer membrane (OM) and inner membrane (IM) of E. coli. Coincident with these events, bacterial synthesis of DNA, RNA, and protein ceased and the colony count fell. Although these events were closely coupled under standard assay conditions, OM permeabilization was partially dissociated from IM permeabilization when experiments were performed with E. coli that had been plasmolyzed by mannitol. Under such conditions, the rate and extent of bacterial death more closely paralleled loss of IM integrity than OM permeabilization. Electron microscopy of E. coli that had been killed by defensins revealed the presence of striking electron-dense deposits in the periplasmic space and affixed to the OM.
Introduction
The ability of PMN to ingest and kill microorganisms contributes substantially to host defenses against infection. PMNs possess at least two general antimicrobial mechanisms. One of these, often designated "oxygen dependent," results from the PMN's postphagocytic production of°-(superoxide) that is subsequently converted to more potent oxidants such as H202, hydroxyl radical, hypochlorous acid, and chloramines. These stronger oxidants are likely to be the actual effectors of oxygen-dependent microbicidal activity (comprehensively reviewed in reference 1).
The other general microbicidal mechanism, usually called "oxygen independent," results when PMN translocate antimicrobial proteins from cytoplasmic granules to their phagocytic vacuoles. Among these antimicrobial components are defensins (2, 3), cathepsin G (4-6), cationic antimicrobial peptide (CAP)-37 (7) , and three similar or identical proteins, known variously as bactericidal/permeability-increasing protein (B/PI)l (8, 9) , CAP-57 (7), and bactericidal protein (10) .
Defensins are small (Mr 3,500-4,000), carbohydrate-free homologous peptides that exist in human (2, 1 1), rabbit (12) , and guinea pig (13) PMN. The human PMN's three defensins, human neutrophil peptide defensin (HNP)-1, HNP-2, and HNP-3, have identical primary sequences, except for their respective amino terminal residues (3). Human and animal defensins exert in vitro activity against a broad range of grampositive and -negative bacteria (2, 14) , fungi (15, 16) , and enveloped viruses (17, 18) . We undertook these experiments to ascertain the bactericidal mechanism of defensins against a susceptible gram-negative bacterium, Escherichia coli ML-35.
Methods
Organisms. E. coli ML-35, a lactose permease-deficient strain with constitutive cytoplasmic ,3-galactosidase activity (i-, y-, z+), was obtained from Professor S. C. Rittenberg of UCLA. E. coli ML-35p was constructed by transforming E. coli ML-35 with pBR-322 to introduce a periplasmic, plasmid-encoded ,(-lactamase as reported elsewhere (19) . E. coli ML-35 was maintained on trypticase soy agar plates and E. coli ML-35p was passaged on similar plates that periodically contained 100 ,g/ml of ampicillin. Organisms were picked from a single colony and incubated in trypticase soy broth (TSB; BBL Microbiology Systems, Cockeysville, MD) for 18 h at 37°C to provide stationary phase test organisms. These cultures were washed two or three times with 10 mM sodium phosphate buffer, pH 7.4 (NAPB), then adjusted to an OD620 of 0.35 (-1 X 108 CFU/ml) and kept on ice until used.
Peptides and reagents. Defensins were prepared from human peripheral blood leukocytes as previously described (2) . Experiments were done with either purified HNP-I or a mixture of two or three defensins, as described in the text. Working stock solutions of defensins were usually prepared at 1 mg/ml in 0.01% acetic acid. Other reagents and their suppliers were: 7-[(thienyl-2-acetamido)-3- (2-(4- N,N-dimethylaminophenylazo)-pyridinium-methyl)-3-ephem-car- Membrane permeabilization. To measure inner membrane (IM) permeabilization, washed stationary phase (18 h) E. coli ML-35 were added to a cuvette that contained 1.67 mM ONPG in NAPB-TSB, a medium that contained NAPB, pH 7.4, and a 1:100 dilution of fullstrength TSB. When we assessed IM and outer membrane (OM) permeabilization concurrently, E. coli ML-35p replaced E. coli ML-35, and both PADAC, a ,B-lactamase substrate, and 1.67 mM ONPG were present in the cuvettes. In most cases we measured OD every 1 or 2 min at 660, 570 (or 595 nm), and 400 nm (ONPG) as previously described (19) . All spectrophotometric studies were performed in a spectrophotometer (model DU-8; Beckman Instruments, Inc., Palo Alto, CA) with a Peltier temperature controller. Cuvettes contained 0.6-3.0 ml, depending on the number and volume of samples to be removed during the incubation.
In some experiments we used a modified version of the previously described multiple wavelength assay, and expressed OM and IM permeabilization relative to that of fully permeabilized bacteria. The essential elements of this more quantitative procedure will be described below. Data reduction was performed with Lotus 1-2-3 software (Lotus Development Corp., Cambridge, MA).
Modified spectrophotometric assay. The effects ofdefensins on permeability of the OM and IM of E. coli ML-35p was determined as follows. Our primary data consisted of sets of measurements of OD at 660 nm [1] , 570 or 595 nm [2] , and 400 nm [3] taken at regular intervals, usually 1 or 2 min. In the formulas that follow, the initial readings at these wavelengths are denoted by a subscript, e.g., [lo] or [20] . Although the following formulas also apply if different wavelengths are chosen, the numerical values of k,, k2, k3, and k4 will change. Explanation: the primary data sets [ 1] , [2] , and [3] are used to calculate AOD660 [4] , AOD595 [5] , and AODo [11] . All OD changes that occurred at 660 nm are attributable to alterations in light scattering by the bacteria. Although most ofthe OD change at 570 or 595 nm is due to PADAC hydrolysis (reflecting OM permeability), a small component arises from changes in light scattering and is, orrected for in [6] .
After complete hydrolysis of PADAC by ,B-lactamase, some residual light absorption persists at 595 nm, attributable to PADAC's hydrolysis product. Its extent can be measured by allowing E. coli #B-lactamase to hydrolyze PADAC to completion, and used to define a constant, k2, that equals the initial OD595/(initial OD595 -final OD595) and is used in [7] .
Cumulating the readings in [7] provides the total amount of PADAC consumed [8] . By subtracting the amount of PADAC consumed [8] from the amount initially present ([20] -ki [lo]), the residual PADAC concentration is calculated [9] . Because PADAC hydrolysis in this system was first order with respect to substrate concentration for PADAC concentrations up to 100 MM (data not shown), we normalized the instantaneous rates of PADAC consumption [7] to the concentration ofsubstrate that was present at the outset ofthe reaction. This is shown in [10] , which multiplies the corrected instantaneous rate2 of PADAC hydrolysis [7] by a factor equal to the initial PADAC concentration ([20] -k1[Io]) divided by the residual PADAC concentration [9] .
The rate of ONPG hydrolysis is calculated more simply by correcting the measured DOD400 [ 1 1] for contributions made by PADAC's hydrolysis product [12] and for bacterial light scattering [13] . The turbidity constants k, and k4 were determined by scanning E. coli (1 X 107 CFU/ml) at 660, 595, and 400 nm. The factor, k3, indicating the contribution of PADAC hydrolysis to absorbance at 400 nm, was determined experimentally as previously described by monitoring the change in absorbance at both wavelengths when PADAC was hydrolyzed by purified ,B-galactosidase (19) .
To determine the maximal rate of ONPG [k5] and PADAC [k6] hydrolysis by fully permeabilized cells, we removed samples of defensin-treated bacteria from the cuvettes, placed them in a melting ice bath, and applied three 15-s cycles ofsonication at 70% power with the small probe of a Bronson Biosonic IV sonicator (VWR Scientific Inc., San Francisco, CA). These sonicates were incubated with ONPG and PADAC. In most instances the total enzyme activity in defensintreated cells remained constant during the assay (Fig. 5 ) and a sample removed at 20 min was adequate.
Before deciding on sonication to fully permeabilize the bacteria, we also tried toluene and a variety of surface-active compounds, none of which were better than sonication in our hands (data not shown). To express IM permeabilization as a percent of maximal, we divided the corrected AOD4w [ 13] by the reaction rate recorded by sonicated cells
[k5] as shown in [14] . OM permeabilization was calculated in an analogous manner, by dividing the fully corrected rate ofPADAC hydrolysis [10] by the reaction rate measured in sonicated cells (k6), as in [15] .
Isotope incorporation. At intervals, 25-M1 samples were removed to measure isotope incorporation. These were mixed with 50 Ml of 2% Triton X-100 in NAPB and diluted with 2.5 ml of cold 10% TCA. Duplicate l-ml aliquots were deposited on GFC/C glass fiber filters (Whatman LabSales, Hillsboro, OR). These were washed three times with 1 ml of cold 5% TCA and once with methanol and placed in minivials containing 5 ml ofACS counting fluid (Amersham Corp.). Radioactivity was measured with an LS-100 liquid scintillation counter (Beckman Instrument, Inc., Palo Alto, CA). Electron microscopy. Four 10-ml samples that contained E. coli ML-35p (5 X 107 CFU/ml) in NAPB-TSB were preincubated for 30 min at 37°C. To three of these samples we added defensins (100 Mg/ml ofan equimolar mixture of HNP-I and -2), while the fourth, a control, received an equivalent vol of 0.01% acetic acid (80 MM, final concentration). A pilot sample containing PADAC, whose composition was otherwise identical to the samples prepared for electron microscopy, was monitored to time the onset of OM permeabilization. Samples for electron microscopy were harvested after 20, 30, and 60 min. After removing a small portion of these samples for CFU/ml measurements, the remainder was centrifuged for 10 min at 2,800 g. Pellets were resuspended and fixed for 1 h in 2.5% glutaraldehyde/0.75 M cacodylate buffer, pH 7.4, and postfixed for an additional h with 1% OS04 in 2. In this description the rate formulas were written in a time-independent manner because time intervals between measurements were equal. Ifthis were not so, [4] , [5] , and [11] Results IM permeabilization. Intact stationary phase E. coli ML-35 exposed to HNP-l in NAPB remained cryptic for ,B-galactosidase for > 90 min (data not shown). In contrast, when these organisms were exposed to defensins in a nutrient-containing buffer, NAPB-TSB, ONPG hydrolysis occurred, signifying that the IM had become permeable (Fig. 1) .
IM permeabilization occurred after a lag that varied from 12 to -50 min. The lag times were longest when stationary phase bacteria that had not been preincubated in NAPB-TSB were tested. When tests were performed with bacteria that had been preincubated in NAPB-TSB, the lag times were shortened by 1 Although defensin-treated and control E. coli ML-35 displayed equivalent rates of DNA, RNA, and protein synthesis for the first 10-15 min, thereafter macromolecular synthesis ceased completely and concomitantly in defensin-treated bacteria (Fig. 3) . The temporal relationships between IM permeabilization, protein synthesis, and loss of colony forming potential are shown in Fig. 4 . Note that loss of bacterial viability coincided temporally with the loss of IM integrity, as reflected by ONPG hydrolysis.
The uppermost A420 plateau shown in the left portion of the figure is an artefact arising from the spectrophotometer's inability to measure higher ODs. Note also that whereas only two-thirds of the bacteria lost viability ( Figure 3 . Effects of defensins on macromolecular synthesis. After stationary phase E. coli (1 x i07 CFUJ/ml) were preincubated for 30 min in NAPB-TSB at 37°C, concentrated 10-fold, and placed on ice. These bacteria (60 Ml) were diluted 10-fold into NAPB-TSB that contained 50 ,ug/mi of HNP-1,2 (in equimolar amounts). In addition, the assay media contained ['4C]leucine (6 ]leucine (final concentration 1 gCi/ml) and 100 ug/ml HNP-l were added and serial aliquots were removed to measure isotope incorporation and CFU/ml while the cuvette was monitored for ONPG hydrolysis. The plateau in A420 arises from the spectrophotometer's insensitivity to higher ODs, rather than from termination of ONPG hydrolysis.
Effects on enzyme synthesis. We also examined the effects of HNP-l on synthesis of periplasmic (l-lactamase and cytoplasmic ,B-galactosidase by E. coli ML-35p. As shown in Fig. 5 , control bacteria incubated in defensin-free NAPB-TSB synthesized both enzymes in ever-increasing amounts, in proportion to their increasing numbers. In contrast, no net synthesis of either enzyme occurred in the defensin-treated E. coli. OM permeabilization. We investigated the effects of HNP on the OM of E. coli with a procedure that permitted analysis of IM permeabilization in the same sample at the same time (19) . Fig. 6 shows a representative experiment performed with bacteria that had been preincubated for 30 min in NAPB-TSB before addition of HNP-1. Note that the onset of OM and IM permeability occurred -15 min after the defensins had been added. Figure 5 . Effects of HNP-l on enzyme content of E. coli ML-35p. E. coli ML-35p, -2 X 106 CFU/ml, was preincubated in NAPB-TSB with (bottom) or without (top) 50 yg/ml of HNP-l. At intervals, samples were removed for colony count measurements and to measure total enzyme activity in bacterial sonicates. Although this method allowed us to delineate the onset of OM and IM permeabilization, it provided little information about the extent or duration ofthese events. For these reasons, the assay was modified as described in Methods. When we used this modified procedure, OM permeabilization appeared biphasic, with a relatively small early component and a much larger secondary component (Fig. 7) . The secondary phase of OM permeabilization coincided precisely in timing and relative extent with permeabilization of the IM. Fig. 7 also confirms that periplasmic ,B-lactamase was substantially but incompletely cryptic at the outset of the measurement.
Dissociation of OM and IM permeabilization. Although OM and IM permeabilization were tightly coupled in time under our standard test conditions in NAPB-TSB, we could partially dissociate them by conducting the experiment in NAPB-TSB that contained a high concentration (0.5-0.6 M) of mannitol, an osmolyte. Although this dissociation was also evident when the experiments were analyzed according to our simpler, published (19) procedure (Fig. 8) , it was even more distinct when the experiments were analyzed by the more 40 6 TSB that contained 44 quantitative approach described in this report. Unlike our findings in NAPB-TSB (Fig. 7) , HNP-induced OM permeabilization proceeded with unimodal kinetics and went to completion when the target bacteria had been plasmolyzed with mannitol ( Fig. 9 ). Under these conditions, IM permeabilization only progressed to 50% of maximum when results were corrected for the slow but progressive inhibition of ,B-galactosidase by HNP-1 (denoted by solid triangles in the figure). The decreased CFU/ml and the extent ofIM permeabilization were very similar, suggesting that IM perforation rather than OM permeabilization was the lethal event.
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We were unsuccessful in numerous attempts to fully dissociate OM and IM permeabilization by altering the incubation temperature or by making variously timed additions of CCCP, Ca", or chloramphenicol. Although each of these additions could protect the bacterial target cells from defensin-mediated IM permeabilization, they also protected them well from OM permeabilization (data not shown).
Morphological changes. HNP-treated stationary phase E. coli that had been exposed to HNP-1 for 60 min showed several remarkable changes in their electron microscopic appearance (Fig. 10) min of exposure to HNP, and only a few organisms with these changes were evident in the samples fixed after 30 min. Colony counts obtained on aliquots of the 20-, 30-, and 60-min samples before fixation showed 33, 50, and 70% reductions, respectively, suggesting that appearance of these structures followed rather than caused loss of bacterial viability. Indeed, in parallel studies ofdefensin binding we have noted that massive uptake and accumulation of HNP-1 by E. coli ML-35 occurs after establishment of OM/IM permeability (Lehrer et al., unpublished observations). Consequently, posthumously bound defensins may contribute to the striking accretions (funereal warts?) shown in Fig. 9 .
Discussion
We analyzed the bactericidal mechanism ofdefensins against a susceptible strain of E. coli by establishing the chronology and order of four major events: OM permeabilization, IM permeabilization, inhibition of macromolecular synthesis, and loss of colony forming potential. To do so, we developed a procedure that allowed these events to be monitored concurrently in a single reaction vessel, in this case a cuvette. Although all four events were virtually simultaneous when assays were run in a nutrient-supplemented dilute buffer, NAPB-TSB, they were partially dissociated when we performed the experiments with bacterial targets that had been plasmolyzed with mannitol. Under these conditions, defensin-mediated bactericidal activity was correlated with permeabilization of the bacterial IM. Although defensin-induced IM permeabilization appeared to require antecedent OM damage, the partial dissociation of OM and IM permeabilization by mannitol suggests that the outer membrane lesion is insufficient, by itself, to cause microbial death.
Since the outer membrane of E. coli contains porins that normally exclude hydrophilic molecules larger than 700 D from passage into the periplasmic space, the ability of defensins (M, 3,500-4,000) to cause OM damage may bypass this exclusionary mechanism. We have observed that defensintreated, but not native E. coli ML-35 bacteria can be spheroplasted by lysozyme (Lehrer et al., unpublished observations). Since lysozyme molecules are considerably larger than defensins, it is logical to conclude that defensin-mediated OM permeabilization also affords defensins access to the periplasmic space and IM. Sawyer et al. recently reported that a rabbit defensin, NP-1, can permeabilize the OM of Pseudomonas aeruginosa (20) .
Our use of the hydrophilic solute, PADAC, to assess outer membrane permeability of defensin-treated E. coli ML-35p was founded on earlier studies by Zimmerman and Rosselet (19) . Others have used the intact gram-negative outer membrane's ability to exclude small but potentially antimicrobial hydrophobic molecules to assess outer membrane integrity. Among the useful molecular probes in such assays are actinomycin D, Triton X-100, and rifampin (22, 24, 25 defensins did sensitize the organisms to rifampin, suggesting that some degree of defensin-mediated outer membrane permeabilization had occurred. These findings are consistent with the effects of defensins on outer membrane permeability in E. coli ML-35p, described in this report.
We suggest that the synchronous inhibition of RNA, DNA, and protein production in defensin-treated bacteria is a consequence of IM permeabilization, with its attendant loss of cellular metabolites and altered ionic cellular environment. This does not preclude a contribution from other effects of defensins yet to be defined.
That normal human PMN kill ingested gram-negative bacteria with considerable efficacy under anaerobic conditions suggests that these cells possess potent 02-independent bactericidal mechanisms (9, 27, 28) . In addition to defensins, the azurophil granules of human PMN contain two other wellcharacterized components, bactericidal/permeability-increasing protein (B/PI) and cathepsin G, able to kill E. coli in vitro. The actions of B/PI have recently been reviewed by Elsbach and Weiss (reviewed in reference 9). It is believed that electrostatic interactions between B/PI, a cationic molecule, and anionic sites in the bacterial outer membrane precede its hydrophobic insertion into the OM, which causes virtually immediate loss of colony-forming activity and increased OM permeability. Although the OM permeability change is reversible, the bactericidal effect is not. Unlike our findings with defensins, viability and general biosynthetic capacity are dissociated in B/PI-treated bacteria, as macromolecular synthesis continues even after viability is lost (9, 24) .
Odeberg and Olsson reported that cathepsin G, purified from human PMN, killed Staphylococcus aureus 502A and E. coli in vitro (4). Interestingly, logarithmic phase E. coli that had been exposed to cathepsin G remained viable and synthesized macromolecules normally for -20 min. Thereafter, viability fell and macromolecular synthesis was inhibited in proportion to the decrease in colony count. Although these data are strongly suggestive that cathepsin G may also kill E. coli by sequentially attacking OM and IM integrity, this interpretation requires experimental verification.
The interactions between E. coli ML-35 and intact human neutrophils were closely examined by Hamers et al. (29) , who reported that E. coli ML-35 lost its crypticity for fl-galactosidase with pseudo-first order kinetics after ingestion by PMN, and that IM perforation (loss of crypticity) and microbial death were correlated. Because our data show that purified defensins can both perforate and kill E. coli (29) suggest that the MPO-H202-halide system is not required for this intracellular function of intact human neutrophils. Moreover, because Chediak-Higashi PMN lack cathepsin G and other neutral proteases (31) , their findings also suggest that the intraleukocytic permeabilization and killing of E. coli by normal PMN may not require cathepsin G. Although B/PI is thought to participate in the neutrophil's ability to kill ingested E. coli (32) , its ability to perforate the IM of susceptible gram-negative organisms in general and to perforate the OM and IM of smooth organisms such as E. coli ML-35 (33) is not known.
Almost 20 years ago, Friedberg et al. reported that E. coli ML-35 that had been exposed to a crude extract of guinea pig PMN granules lost their crypticity for f3-galactosidase and were killed (34, 35) . He also reported that treated bacteria developed interesting morphological alterations, including spatial separations between their inner and outer membranes that resemble those shown in Fig. 9 . Because at least one defensin (13) is included among the antimicrobial components of guinea pig PMN (36), we suggest that defensins may have contributed to these morphological changes. Rock and Rest (37) recently reported that N. gonorrhoeae exposed to extracts prepared from human neutrophil granules developed structural aberrations of the outer membranes with some resemblance to those we noted in defensin-treated E. coli. The relationship of these changes to those illustrated in Fig. 10 is presently uncertain.
Our finding that target cell growth and metabolism are required to sensitize E. coli ML-35 to the microbicidal effects of human defensins has a counterpart in the earlier studies of Walton and Gladstone (38, 39) and in our more recent studies on the effects of human defensins against C. albicans. Walton and Gladstone (38, 39) examined the effects of the abundant, low molecular weight cationic peptides of rabbit PMN on S. aureus. Originally discovered by Zeya and Spitznagel (40, 41) , who referred to them as lysosomal cationic proteins, these peptides have since been shown to be homologous to human defensins by sequence analysis (12) . Walton and Gladstone found that the ability of these rabbit defensins to kill S. aureus was highly dependent on the target cell's oxidative metabolism. Staphylococci were substantially protected from these peptides by inhibitors of respiration, energy transfer or oxidative phosphorylation (38, 39) . Similarly, C. albicans is highly susceptible to human defensins in vitro only when it exhibits active mitochondrial respiration. It is not killed effectively by defensins under anaerobic conditions or in the presence of various mitochondrial inhibitors (15) . Although relatively few other examples of the regulation of susceptibility to PMN components by microbial energetics or metabolism have been reported (42, 43) , this phenomenon is described with regard to several colicins and bacteriocins (e.g., references [44] [45] [46] and serum complement (47) .
We have shown that human defensins exert bactericidal activity selectively against metabolically active and growing bacteria, and that they attack the outer and inner membranes of E. coli ML-35. It is noteworthy that the ability of defensins to kill fungi (15) and mammalian tumor cells (48) also requires metabolic activity by the target cell. This apparent requirement that target cells participate in their own demise raises Figure 10 . Morphology of defensin-treated E. coli . E. coli ML-35 was exposed to HNP-1,2 for 60 min as described in the text. (A) A longitudinally sectioned organism with electron-dense material in its periplasmic space (arrow anchored by the star) and warty accumulations of electron-dense material adherent to its OM (arrows). (B) Additional bacteria, sectioned more obliquely, showing numerous discrete electrondense OM deposits. The warty OM deposits on HNP-treated bacteria did not always show regular spacing.
interesting questions about the general mechanisms of defensin-mediated target cell killing. Perhaps the molecular design of defensins allows them to subvert some component of cellular energetics into a fatal attraction. As defensins can form voltage-regulated ion channels in model membrane systems (49) their broad lethal spectrum may reflect defensin interactions with features of energized membranes, such as the transmembrane potential or proton motive force, that are common to prokaryotic and eukaryotic cells.
